Physician
Centennial Hills Hospital Medical Center
Centennial Hills Hospital Medical Center was paid $1.13M by Medicaid between Jan 2022 and Dec 2024, across 60 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoCENTENNIAL HILLS HOSPITAL MEDICAL CENTER
LAS VEGAS, NV 89131
LAS VEGAS, NV 89131
33aNPI1295319085assigned 05/08/2021
33bProvider typeEmergency Medicine Physician
28Total paid$1.13M
24GClaims43,877
24DCodes billed60
24AFirst – last monthJan 2022 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Nevada
Rank by total paid#16 of 216
Median peer was paid$63K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 13,199 | $300K | |
| 2023 | 18,323 | $473K | |
| 2024incomplete | 12,355 | $353K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 3,211 | 2,934 | $275K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 2,277 | 2,041 | $234K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 3,139 | 2,938 | $185K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.6% | 398 | 366 | $74K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.7% | 2,039 | 1,710 | $64K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.6% | 749 | 715 | $52K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.7% | 1,452 | 1,204 | $30K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 765 | 700 | $27K |
| 80053 | Comprehensive metabolic panel | 1.2% | 1,907 | 1,693 | $14K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 1,310 | 1,142 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 861 | 828 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 167 | 160 | $12K |
48 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 2,944 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 599 | $12K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 119 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,472 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,171 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 508 | $8K |
| 84702 | <1% | 1,062 | $7K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 627 | $6K |
| 84484 | <1% | 1,379 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,201 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 689 | $6K |
| 83690 | <1% | 1,209 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,072 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 78 | $4K |
| 81001 | <1% | 1,774 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 116 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 806 | $4K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,284 | $2K |
| 81025 | <1% | 654 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 644 | $2K |
| 83605 | <1% | 207 | $2K | |
| 85379 | <1% | 113 | $846.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $781.43 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 27 | $757.54 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 48 | $578.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 634 | $573.89 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 585 | $506.50 |
| 85610 | <1% | 202 | $492.32 | |
| 96376 | <1% | 51 | $489.09 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 78 | $477.20 |
| 81003 | <1% | 295 | $459.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,283 | $411.63 |
| 83735 | <1% | 51 | $287.18 | |
| 73564 | <1% | 12 | $241.61 | |
| 73630 | <1% | 13 | $227.93 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $217.62 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $217.62 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 141 | $169.80 |
| 85730 | <1% | 75 | $165.04 | |
| 87077 | <1% | 47 | $155.68 | |
| 80076 | <1% | 30 | $146.01 | |
| 87186 | <1% | 13 | $70.98 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 63 | $63.01 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 126 | $62.26 |
| 85027 | <1% | 14 | $53.57 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 17 | $13.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 13 | $0.62 |
| 0353U | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (EXEC VP - CFO)
Parent organizationCENTENNIAL HILLS HOSPITAL MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.